The first evidence of surgery, if you can call it that, dates back to the Neolithic and pre-Classical periods where skull trephining took place. The gruesome practice of cutting small holes in the head was thought to rid the body of spirits and was widely practised throughout Europe, Africa and South America. The Egyptians even
Read More
4,440 US hospitals and health systems will soon have access to Avita Medical’s (ASX: AVH) proprietary RECELL System thanks to a purchasing agreement signed with Premier, a leading healthcare improvement company in the US. Premier’s mission is to enable optimal patient care at reasonable cost within their alliance of 4,400 US hospitals and 225,000 other
Read More
Things are well and truly on track for clinical stage pharmaceutical company Pharmaxis (ASX: PXS), a sentiment confirmed by CEO Gary Phillips in his shareholder address in their recent quarterly results. The Company has made significant progress in three clinical trial programs, with plenty on the horizon for their preclinical pipeline too. Lead asset PXS-5505
Read More
Of all the places in the world where you thought a cure for Parkinson’s disease might be found, the remote sub-Antarctic Auckland Islands might not have been your first choice but that’s exactly where biotech company Living Cell Technologies (ASX: LCT) will obtain tissue for their clinical trials. Specifically, Living Cell Technologies has secured a
Read More
Let’s rewind to Year 10 biology- you know that mitochondria is the powerhouse of the cell, chances are you vaguely remember the golgi apparatus but do you remember what an exosome is? Exosomes, or extracellular vesicles are little packages delivering molecules and enhancing cell-to-cell communication. Clinical- stage biopharmaceutical company Exopharm (ASX: EX1) is utilising exosomes
Read More
We live in the age of optimisation. Constantly asking questions like how can we be more efficient? How can we streamline processes? How can we enhance ourselves with the resources available? The pharmaceutical scene is no different, seeking to optimise drugs in any way possible to produce better patient outcomes. Biopharmaceutical company Starpharma (ASX: SPL)
Read More